Issue price | 153.42 |
Initial fixing date | 31.01.2020 |
Payment day | 07.02.2020 |
First trading day | 07.02.2020 |
Last trading day | 31.12.2999 |
Final fixing day | 31.12.2099 |
Redemption date | open end |
Redemption type | Cash Settlement |
Early redemption | No |
Residual term | open end |
Issue amount | 10'000'000.00 |
Price status | flat Marchzins |
Exchange | SIX Structured Products |
Trade time | 09:15 - 17:15 (CET) |
Round lot | 1 |
Performance of underlying since issue |
SSPA derivative category | Participation |
SSPA code | Tracker certificate (1300) |
Issuer | Zürcher Kantonalbank, Zürich |
Keep-Well Agreement | |
Issuer rating | Standard & Poor's AAA, Moody's Aaa, Fitch AAA |
Lead manager | Zürcher Kantonalbank, Zürich |
Payment, execution and calculation agent | Zürcher Kantonalbank, Zürich |
Income tax | No |
Withholding tax | No |
Stamp duty payable in the secondary market | No |
Stamp duty payable upon delivery of the securities | No |
SIX Telekurs EU tax classification code | 0 (out of scope) |
Internal Rate of Return | n.a. |
Cash value of fixed income investment upon issue | n.a. |
Cash value of fixed income investment upon redemption | n.a. |
USA, US persons, EEA, Guernsey, QZ |
Redemption date | 31.12.2099 |
Redemption amount | |
Redemption currency | n.a. |
Underlying | n.a. |
Physical delivery | - |
ZKB Barrier Reverse Convertible mit bedingtem Coupon on worst of Salesforce.com Inc/NVIDIA Corp/Supe... 132913957 / CH1329139575 |
ZKB Autocallable Barrier Reverse Convertible on worst of Biogen Inc/BioNTech SE/Moderna Inc 132913422 / CH1329134220 |
ZKB Reverse Convertible auf Moderna Inc 135805537 / CH1358055379 |
22.09% ZKB Reverse Convertible, 16.01.2025 on worst of NVDA UW/TSLA UW/MRNA UW NVIDIA Corp/Tesla Inc... 130398418 / CH1303984186 |
11.17% ZKB Reverse Convertible, 03.03.2025 on worst of QCOM UW/AAL UW/MRNA UW Qualcomm Inc/American ... 135805027 / CH1358050271 |